Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» breast cancer
breast cancer
Study cracks open the secrets of the cancer-causing BRCA1 gene
Stat
Wed, 09/12/18 - 07:20 pm
Myriad Genetics
genetic testing
BRCA1
R&D
breast cancer
ovarian cancer
Cancer researcher never disclosed millions received from medical journals
Health Exec
Mon, 09/10/18 - 08:12 pm
breast cancer
physicians
physician payments
Good Phase III results for Novartis’ cancer drug (breast cancer)
GoinPharma
Sun, 08/26/18 - 12:05 pm
Novartis
clinical trials
breast cancer
BYL719
alpelisib
Novartis’ PI3K drug hits goal in phase 3 breast cancer trial, laying groundwork for talks with regulators
Fierce Biotech
Thu, 08/23/18 - 10:19 am
Novartis
PI3k inhibitor
BYL719
clinical trials
breast cancer
SBIR Awards $2.3 Million Grant to Agilvax to Advance Immunotherapy for Triple Negative Breast Cancer
Tue, 08/7/18 - 09:59 am
Agilvax
AX09
breast cancer
A slowing market—not new rivals—is hurting Pfizer's star cancer drug Ibrance, executives say
Fierce Pharma
Wed, 08/1/18 - 11:50 pm
Pfizer
Ibrance
breast cancer
Endomagnetics’ device could help ID cancerous lymph nodes
Mass Device
Wed, 07/25/18 - 03:09 pm
Endomagnetics
devices
breast cancer
lymph node biopsies
FDA Approves First Cancer Drug Under New Real Time Review Program
CP Wire
Wed, 07/18/18 - 01:39 pm
FDA
Novartis
Kisqali
breast cancer
Scott Gottlieb
Real Time Oncology Review
FDA Approves First Cancer Drug Under New Real Time Review Program
Wed, 07/18/18 - 01:38 pm
FDA
Scott Gottlieb
Kisqali
breast cancer
Seattle Genetics Announces Results of Two Ph II Trials of Tucatinib in HER2- Positive Metastatic Breast Cancer
CP Wire
Wed, 07/11/18 - 10:12 am
Seattle Genetics
tucatinib
orphan drugs
clinical trials
HER2-positive metastatic breast cancer
breast cancer
Seattle Genetics Announces Results of Two Ph II Trials of Tucatinib in HER2- Positive Metastatic Breast Cancer
Wed, 07/11/18 - 09:37 am
Seattle Genetics
tucatinib
breast cancer
HER2-positive metastatic breast cancer
CHMP reverses course on neratinib, handing Puma an unexpected win on European marketing vote — shares soar
Endpoints
Tue, 06/26/18 - 11:58 am
Puma Biotechnology
Europe
CHMP
EMA
neratinib
Nerlynx
breast cancer
Arcus Biosciences and Infinity Pharmaceuticals Partner to Evaluate Triple-Combination Therapy in Breast and Ovarian Cancer
CP Wire
Tue, 06/26/18 - 09:43 am
Arcus Biosciences
Infinity Pharmaceuticals
drug development
IPI-549
AB928
AB122
breast cancer
ovarian cancer
Arcus Biosciences and Infinity Pharmaceuticals Partner to Evaluate Triple-Combination Therapy in Breast and Ovarian Cancer
Tue, 06/26/18 - 09:23 am
Arcus Biosciences
Infinity Pharmaceuticals
breast cancer
ovarian cancer
Pfizer's breast cancer drug combo falls short of survival goal
Yahoo/Reuters
Mon, 06/25/18 - 12:42 pm
Pfizer
breast cancer
Ibrance
clinical trials
Pfizer's PARP Inhibitor Talazoparib Gets FDA Priority Review and EMA Submission
CP Wire
Thu, 06/7/18 - 12:07 pm
Pfizer
talazoparib
BRCA-mutant breast cancer
breast cancer
metastatic breast cancer
FDA
EMA
priority review
Pfizer's PARP Inhibitor Talazoparib Gets FDA Priority Review and EMA Submission
Thu, 06/7/18 - 12:04 pm
Pfizer
talazoparib
BRCA-mutant breast cancer
breast cancer
Why Data at ASCO 2018 Sent Immunomedics Shares Soaring Today
Motley Fool
Mon, 06/4/18 - 10:09 pm
Immunomedics
ASCO 2018
sacituzumab govitecan
breast cancer
Many Breast Cancer Patients Can Safely Skip Chemo, Large Trial Confirms
Forbes
Sun, 06/3/18 - 10:27 am
early-stage breast cancer
breast cancer
chemotherapy
Oncotype DX
diagnostics
Genomics Health
ASCO 2018
Breast Cancer Cells Use In-House Recycling To Survive After Spreading
Forbes
Tue, 05/22/18 - 06:03 pm
breast cancer
metastatic breast cancer
autophagy
Novartis
Pfizer
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »